| First Author | Branca C | Year | 2017 |
| Journal | Hum Mol Genet | Volume | 26 |
| Issue | 24 | Pages | 4823-4835 |
| PubMed ID | 29036636 | Mgi Jnum | J:252194 |
| Mgi Id | MGI:6094529 | Doi | 10.1093/hmg/ddx361 |
| Citation | Branca C, et al. (2017) Genetic reduction of Nrf2 exacerbates cognitive deficits in a mouse model of Alzheimer's disease. Hum Mol Genet 26(24):4823-4835 |
| abstractText | Aging is the major risk factor for several neurodegenerative diseases, including Alzheimer's disease (AD). However, the mechanisms by which aging contributes to neurodegeneration remain elusive. The nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is a transcription factor that regulates expression of a vast number of genes by binding to the antioxidant response element. Nrf2 levels decrease as a function of age, and reduced Nrf2 levels have been reported in postmortem human brains and animal models of AD. Nevertheless, it is still unknown whether Nrf2 plays a role in the cognitive deficits associated with AD. To address this question, we used a genetic approach to remove the Nrf2 gene from APP/PS1 mice, a widely used animal model of AD. We found that the lack of Nrf2 significantly exacerbates cognitive deficits in APP/PS1, without altering gross motor function. Specifically, we found an exacerbation of deficits in spatial learning and memory, as well as in working and associative memory. Different brain regions control these behavioral tests, indicating that the lack of Nrf2 has a global effect on brain function. The changes in cognition were linked to an increase in Abeta and interferon-gamma (IFNgamma) levels, and microgliosis. The changes in IFNgamma levels are noteworthy as previously published evidence indicates that IFNgamma can increase microglia activation and induce Abeta production. Our data suggest a clear link between Nrf2 and AD-mediated cognitive decline and further strengthen the connection between Nrf2 and AD. |
